机译:胰岛素原特异性,HLA-DQ8和HLA-DQ8-二聚体限制型CD4〜+ T细胞浸润1型糖尿病的胰岛
Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia;
Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia;
Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia;
Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia,Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia;
Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia;
Department of Medicine, University of Adelaide, Adelaide, South Australia, Australia;
Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia,Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia;
National Pancreas Transplant Unit, University of Sydney at Westmead Hospital, Sydney, New South Wales, Australia;
Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia;
University of Melbourne, Northwest Academic Centre, Sunshine Hospital, St. Albans, Victoria, Australia;
Department of Paediatrics, Monash University, Clayton, Victoria, Australia;
Department of Paediatrics, Monash University, Clayton, Victoria, Australia;
Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia;
Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia;
Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia,Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia;
Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia,Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia;
Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia,Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia;
机译:CD8 T细胞对胰岛抗原的反应性是1型独有的,而CD4 T细胞反应性在1型和2型糖尿病中都存在
机译:伴有或不伴有β细胞的巨噬细胞和树突状细胞浸润胰岛会在新近发病的1型糖尿病患者中产生肿瘤坏死因子-α
机译:HLA-DQ8纯合性与杂合性对1型糖尿病胰岛自身免疫的功能影响。
机译:实验性2型糖尿病和大鼠注射氨基邻苯二甲酰肼钠后Pdxl基因的产生和胰岛外阳性细胞
机译:评价血液细胞抑制免疫应答的潜在用途的潜在用途,作为临床胰岛移植在临床胰腺移植中的含有型1型糖尿病的替代品
机译:产妇的微嵌合体:1型糖尿病胰腺的胰岛素阳性隔室中增加但不渗入免疫细胞或复制胰岛细胞中。
机译:胰岛素原特异性,HLa-DQ8和HLa-DQ8-转录子限制性CD4(+)T细胞浸润1型糖尿病胰岛